Advancing high content analysis towards improving clinical efficacy

European Pharmaceutical Review

Volumn , Issue 1, 2011, Pages

  Carragher, Neil ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CONTENT ANALYSIS; DIAGNOSTIC IMAGING; DRUG DEVELOPMENT; DRUG INDUSTRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; MEDICAL TECHNOLOGY; PROTEOMICS; REVIEW; SYSTEMS BIOLOGY;

EID: 79955054506     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (17)

1. Sams-Dodd F. (2005). Target-based drug discovery: is something wrong? Drug Discov Today. 10, 139-147
2. Butcher EC. (2005). Can cell systems biology rescue drug discovery. 4, 461-467
3. Zock JM. (2009). Applications of High content screening in life science research. Combinatorial Chemistry & high throughput screening. 12, 870-876
4. Alcock P, Bath C, Blackett C and Simpson PB (2010). High content cell based primary screening for oncology targets - a perspective. 3. June 25
5. Ting AY, Kain KH, Klemke RL and Tsien RY (2001). Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl. Acad. Sci. USA 97, 2253-258
6. Baatz M, Arini N, Schape A, Binnig G and Linssen B (2006). Object-orientated image analysis for high content screening: detailed quantification of cells and sub cellular structures with the cellenger software. Cytometry Part A. 69:652-658 (Pubitemid 44060599)
7. Jones TR, Kang IH, Wheeler DB, Lindquist RA, Papallo A, Sabatini DM and Golland P (2008). BMC Bioinformatics.Nov 15;9:482
8. Barbaric I, Gokhale PJ and Andrews PW (2010) High-content screening of small compounds on human embryonic stem cells. Biochem. Soc. Trans. 38(4), 1046-1050
9. Berthier E Surfus J, Verbsky J, Huttenlocher A and Beebe D (2010). An arrayed high-content chemotaxis assay for patient diagnosis. Integr. Biol. 2 630-638
10. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio- Donahue C, Griffiths J, Tuveson DA(2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 12;324(5933):1400-1
11. Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE and Condeelis JS (2005). Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 15: 138-145 (Pubitemid 40332536)
12. Serrels A, Timpson P, Canel M, Carragher NO, Frame MC, Brunton VG, Anderson KI. (2009). Comparison of cell adhesion and membrane dynamics in vitro and in living mice using photo-activation and -bleaching. Cancer Res. 69(7):2714-9
13. Mohammed RA, Ellis IO, Elsheikh S, Paish EC, Martin SG (2008). Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Breast Cancer Res Treat. 113:261-273
14. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF and Altschuler SJ. (2004). Multidimensional drug profiling by automated microscopy. Science 004;306:1194-8 (Pubitemid 39489001)
15. Tanaka M, Bateman R, Rauh D, et al. An unbiased cell morphology based screen for new, biologically active small molecules.(2005). PLoS Biol 2005;3:e128
16. Young DW, Bender A, Hoyt J, et al. (2008). Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol. 4:59-68 (Pubitemid 350273652)
17. Caie P, Walls R, Ingleston-Orme A, Daya S, Houslay T, Eagle R, Roberts M and Carragher NO (2010). High- Content phenotypic profiling of drug response signatures across distinct cancer cells.Mol. Cancer Therap. 9(6) 1913-1926